Met Life Investment Management, LLC Eq Rx, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 09, 2024	BUY	$1.66 - $2.31 $101,384 - $141,083	61,075 Added 55.28%	171,551 $380,000
Q2 2023 Apr 29, 2024	BUY	$1.61 - $1.96 $276,197 - $336,239	171,551 New	171,551 $319,000
Q2 2023 Aug 10, 2023	BUY	$1.61 - $1.96 $98,330 - $119,707	61,075 Added 55.28%	171,551 $319,000
Q1 2023 May 09, 2024	BUY	$1.8 - $2.83 $198,856 - $312,647	110,476 New	110,476 $214 Million
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $32,436 - $50,996	18,020 Added 19.49%	110,476 $214,000
Q4 2022 May 10, 2024	SELL	$2.05 - $5.5 $38,810 - $104,126	-18,932 Reduced 17.0%	92,456 $227,000
Q4 2022 Jun 14, 2023	SELL	$2.05 - $5.5 $36,941 - $99,110	-18,020 Reduced 16.31%	92,456 $227,000
Q4 2022 Mar 22, 2023	SELL	$2.05 - $5.5 $38,810 - $104,126	-18,932 Reduced 17.0%	92,456 $227,000
Q4 2022 Feb 15, 2023	SELL	$2.05 - $5.5 $38,810 - $104,126	-18,932 Reduced 17.0%	92,456 $227,000
Q3 2022 May 10, 2024	BUY	$0.94 - $5.99 $34,511 - $219,916	36,714 Added 49.17%	111,388 $551,000
Q3 2022 Jun 14, 2023	BUY	$0.94 - $5.99 $857 - $5,462	912 Added 0.83%	111,388 $551,000
Q3 2022 Mar 22, 2023	BUY	$0.94 - $5.99 $34,511 - $219,916	36,714 Added 49.17%	111,388 $551,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $34,511 - $219,916	36,714 Added 49.17%	111,388 $551,000
Q2 2022 May 10, 2024	BUY	$3.2 - $5.69 $238,956 - $424,895	74,674 New	74,674 $350,000
Q2 2022 Jun 20, 2023	SELL	$3.2 - $5.69 $114,566 - $203,713	-35,802 Reduced 32.41%	74,674 $350,000
Q2 2022 Mar 22, 2023	SELL	$3.2 - $5.69 $56,902 - $101,179	-17,782 Reduced 19.23%	74,674 $350,000
Q2 2022 Aug 11, 2022	BUY	$3.2 - $5.69 $238,956 - $424,895	74,674 New	74,674 $350,000

Others Institutions Holding EQRX

# of Institutions

Shares Held

67.8M

Call Options Held

Put Options Held

Ah Equity Partners Bio Iii, L.L.C. Menlo Park, CA

19.2M
Shares

$0
100.0% of portfolio
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA

17.4M
Shares

$0
60.15% of portfolio
Arboretum Ventures, Inc.

13.9M
Shares

$0
63.96% of portfolio
Ah Equity Partners Lsv I, L.L.C. Menlo Park, CA

11.4M
Shares

$0
8.42% of portfolio
Ah Equity Partners Lsv Ii, L.L.C. Menlo Park, CA

5M
Shares

$0
11.61% of portfolio

View Full List

About EQRx, Inc.

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

More about EQRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account